Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Preferred Dividend Payments: 2016-2017

Historic Preferred Dividend Payments for Viridian Therapeutics, Inc.\DE (VRDN) over the last 1 years, with Mar 2017 value amounting to $5,000.

  • Viridian Therapeutics, Inc.\DE's Preferred Dividend Payments rose 141.67% to $5,000 in Q1 2017 from the same period last year, while for Mar 2017 it was $42,000, marking a year-over-year change of. This contributed to the annual value of $5,000 for FY2017, which is 89.80% down from last year.
  • According to the latest figures from Q1 2017, Viridian Therapeutics, Inc.\DE's Preferred Dividend Payments is $5,000, which was down 58.33% from $12,000 recorded in Q4 2016.
  • In the past 5 years, Viridian Therapeutics, Inc.\DE's Preferred Dividend Payments registered a high of $13,000 during Q3 2016, and its lowest value of -$12,000 during Q1 2016.
  • Over the past 2 years, Viridian Therapeutics, Inc.\DE's median Preferred Dividend Payments value was $12,000 (recorded in 2016), while the average stood at $6,000.
  • Data for Viridian Therapeutics, Inc.\DE's Preferred Dividend Payments shows a peak YoY soared of 141.67% (in 2017) over the last 5 years.
  • Viridian Therapeutics, Inc.\DE's Preferred Dividend Payments (Quarterly) stood at $12,000 in 2016, then surged by 141.67% to $5,000 in 2017.
  • Its Preferred Dividend Payments stands at $5,000 for Q1 2017, versus $12,000 for Q4 2016 and $13,000 for Q3 2016.